Literature DB >> 7585574

Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity.

M J Allalunis-Turner1, L G Lintott, G M Barron, R S Day, S P Lees-Miller.   

Abstract

Lack of DNA-dependent protein kinase (DNA-PK) activity confers radiosensitivity and defective DNA double-strand break repair. Nine human malignant glioma cell lines were studied to determine whether differences in DNA-PK activity reflect differences in inherent radiosensitivity or are predictive of tumor treatment response. DNA-PK activity was present in all cell extracts, as were the DNA-PK proteins, DNA-PK catalytic subunit, Ku p70, and Ku p80. No correlation was found between the levels of DNA-PK activity and inherent radiosensitivity or in the tumor treatment response. These preliminary results suggest that variation in DNA-PK activity may not be a determinant of clinical response in malignant glioma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585574

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Cisplatinum and taxol induce different patterns of p53 phosphorylation.

Authors:  G Damia; L Filiberti; F Vikhanskaya; L Carrassa; Y Taya; M D'incalci; M Broggini
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Functional interplay between caspase cleavage and phosphorylation sculpts the apoptotic proteome.

Authors:  Melissa M Dix; Gabriel M Simon; Chu Wang; Eric Okerberg; Matthew P Patricelli; Benjamin F Cravatt
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

3.  Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0.

Authors:  S P Lees-Miller; M C Long; M A Kilvert; V Lam; S A Rice; C A Spencer
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis.

Authors:  Q Song; S P Lees-Miller; S Kumar; Z Zhang; D W Chan; G C Smith; S P Jackson; E S Alnemri; G Litwack; K K Khanna; M F Lavin
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

Review 5.  The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies.

Authors:  Semer Maksoud
Journal:  Mol Neurobiol       Date:  2022-06-13       Impact factor: 5.682

6.  Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity.

Authors:  D P Gately; J C Hittle; G K Chan; T J Yen
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

7.  PRKDC mutations in a SCID patient with profound neurological abnormalities.

Authors:  Lisa Woodbine; Jessica A Neal; Nanda-Kumar Sasi; Mayuko Shimada; Karen Deem; Helen Coleman; William B Dobyns; Tomoo Ogi; Katheryn Meek; E Graham Davies; Penny A Jeggo
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

8.  Inhibition of Snail1-DNA-PKcs protein-protein interface sensitizes cancer cells and inhibits tumor metastasis.

Authors:  Ga-Young Kang; Bo-Jeong Pyun; Haeng Ran Seo; Yeung Bae Jin; Hae-June Lee; Yoon-Jin Lee; Yun-Sil Lee
Journal:  J Biol Chem       Date:  2013-10-01       Impact factor: 5.157

9.  The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer.

Authors:  M Someya; K-i Sakata; Y Matsumoto; R P Kamdar; M Kai; M Toyota; M Hareyama
Journal:  Br J Cancer       Date:  2011-05-10       Impact factor: 7.640

10.  Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing.

Authors:  Q Song; S R Burrows; G Smith; S P Lees-Miller; S Kumar; D W Chan; J A Trapani; E Alnemri; G Litwack; H Lu; D J Moss; S Jackson; M F Lavin
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.